Yondelis

Trabectedin (Yondelis) is a chemotherapy medication used for treating specific cancers. Administered intravenously, it targets advanced soft tissue sarcoma and ovarian cancer. This prescription drug requires careful medical supervision for safe use.

Trabectedin is primarily used to treat advanced soft tissue sarcoma when other treatments have not worked. It is also prescribed for relapsed ovarian cancer in combination with other medications. Patients often ask, 'what is Trabectedin used for?' as it targets cancer cells directly. This drug is part of systemic therapy for solid tumors.

Trabectedin works by interfering with cancer cell growth, slowing or stopping tumor progression. Common effects include fatigue, nausea, and lowered blood cell counts. Some patients may experience changes in liver function or muscle pain. These effects vary based on individual health and treatment plans.

Trabectedin should only be handled and administered by healthcare professionals due to its potency. Patients must undergo regular blood tests to monitor for side effects like low blood counts. Liver function and heart health are also closely tracked during treatment. Avoid exposure to infections and report unusual symptoms immediately.

Trabectedin may interact with strong CYP3A inhibitors or inducers, affecting its effectiveness. Grapefruit products and certain antibiotics or antifungals can alter its metabolism. Alcohol and other medications metabolized by the liver may increase side effects. Always inform your doctor about all medications and supplements being used.